A 31-year-old patient has been taking lisinopril 30 mg daily for hypertension for two weeks; morning blood pressure is approximately 110/65 mmHg and evening blood pressure is 135/70‑80 mmHg, with a target ≤130/80 mmHg. What is the next step in blood pressure management?

Continue Current Lisinopril 30 mg Dose and Reassess in 2-4 Weeks

The next step is to continue the current lisinopril 30 mg daily dose and reassess blood pressure control in 2-4 weeks before making any medication changes. Two weeks is insufficient time to evaluate the full antihypertensive effect of lisinopril, and the patient's blood pressure is already showing reasonable control with only isolated evening elevations.

Rationale for Waiting

Timing of Full Drug Effect

• Lisinopril requires 2-3 days to reach steady state but the full antihypertensive effect may take longer to manifest 1, 2
• The patient has only been on 30 mg for 2 weeks, which is at the lower end of the time needed to assess efficacy
• Peak serum concentrations occur 6-8 hours after dosing, with effects lasting at least 24 hours 2

Current Blood Pressure Status

The patient's blood pressure pattern shows:

• Morning BP of 110/65 mmHg is well-controlled and actually below the target of <130/80 mmHg 3
• Evening BP of 135/70-80 mmHg is only marginally above target (systolic 5 mmHg over goal, diastolic at or below goal)
• The 2025 AHA/ACC guidelines target BP <130/80 mmHg, which should be based on an average of ≥2 readings at ≥2 visits, not individual measurements 4

Guideline-Based Monitoring Timeline

According to the 2020 ISH guidelines, BP control should be achieved within 3 months of initiating or adjusting therapy 3. The patient is only at the 2-week mark, leaving substantial time for optimization.

Alternative Considerations if Adjustment Needed After 4-6 Weeks

If evening blood pressure remains elevated after 4-6 weeks of the current dose, consider these options in order:

Option 1: Split Dosing (Preferred if adjustment needed)

• Change to lisinopril 15 mg twice daily (morning and evening) rather than increasing total daily dose
• Evidence shows twice-daily dosing of the same total daily dose provides superior blood pressure control compared to once-daily dosing 5
• A retrospective study demonstrated 10.2/4.3 mmHg greater reduction with twice-daily versus once-daily administration of the same total dose 5
• This approach specifically addresses the evening BP elevation without risking excessive morning hypotension

Option 2: Add a Second Agent

If split dosing is insufficient or not tolerated, follow the ISH stepwise approach for non-Black patients 3:

• Add a dihydropyridine calcium channel blocker (DHP-CCB) such as amlodipine 5 mg daily
• Alternatively, add a thiazide-like diuretic (e.g., chlorthalidone 12.5 mg or hydrochlorothiazide 12.5-25 mg) 1
• The FDA label supports adding a low-dose diuretic if BP is not controlled with lisinopril alone 1

Option 3: Increase Total Daily Dose

• The usual dosage range for lisinopril is 20-40 mg daily 1
• Could increase to 40 mg once daily, though this is less likely to address the evening elevation specifically
• Doses up to 80 mg have been used but do not appear to provide greater effect 1

Important Caveats

Avoid Premature Escalation

• The morning BP of 110/65 mmHg indicates the current dose is providing substantial effect
• Increasing the dose prematurely risks excessive morning hypotension, which can cause syncope, falls, and reduced quality of life
• The 2025 AHA/ACC guidelines emphasize that hypotension and syncope are recognized adverse events of intensive therapy 4

Check Medication Adherence and Timing

• Verify the patient is taking lisinopril consistently at the same time each morning
• Confirm proper BP measurement technique using a validated device with appropriate cuff size 3
• Consider having the patient measure BP at multiple times throughout the day to better characterize the pattern

Monitor for Adverse Effects

• Check a basic metabolic panel 2-4 weeks after any dose adjustment to assess for hyperkalemia or changes in creatinine 4
• Monitor for symptoms of hypotension, particularly with morning readings already at 110/65 mmHg

Target Blood Pressure

The target BP is <130/80 mmHg based on current guidelines 3, 4. For this 31-year-old patient without specified high-risk features (CVD, CKD, diabetes, organ damage), this target is appropriate and should be individualized based on tolerability.